BASELINE PATIENTS' CHARACTERISTICS FROM NAVIGATE, A SEAMLESS ADAPTIVE PHASE 2B/3 TRIAL OF BELAPECTIN IN MASH CIRRHOSIS AND PORTAL HYPERTENSION
HEPATOLOGY(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined